[5-min read] Study suggests ketamine slows or reverses biological aging.
[5-min read] Q&A with Olivia MacDonell, Integration Specialist
[5-min read] Psilocybin beats escitalopram in well-being beyond depression.
[6-min read] Q&A with Rick Doblin, Activist & Founder
[5-min read] Study estimates 5 million Americans would benefit from psilocybin.
[5-min read] Q&A with April Pride, Creative Entrepreneur
[5-min read] AI-powered psychedelic company is approved to launch human trials.
[5-min read] Q&A with Amaฬnda Efthimiou, Consultant & Coach
[5-min read] FDA and DEA schedule public hearings on psychedelics.
[5-min read] Q&A with Stephanie Karzon Abrams, Neuropharmacologist & Founder
[5-min read] MindBio shares durability data from LSD microdosing study.
[6-min read] Q&A with Carlos Tanner, Curandero & Founder
